Regarded by some as the clearance experts, DCR’s two clinical pharmacology centers offer a broad range of experience within the clinical pharmacology space
Deep depth of experience in the areas of
Hepatic/renal clearance
Drug-drug interaction
Food-effect
AME radio-label trials
Maintain ready access to a robust and expanding population of these patients for many years
Extensive track record
Performed more than 15 such trials over the last five years
Enrolled 200+ hepatic subjects in trials since 2013
Average enrollment time-frame of 4-6 months
Robust database of hepatic impaired volunteers is comprised of patients ranging from cirrhotic to Hepatitis C positive
Offer a single source, multi-site full service solution for clinical trials with Hepatic subjects
Two-site solution offering 122 bed footprint
Minneapolis, Minnesota
Denver, Colorado
Harmonized SOPs for the delivery of quality data
30 years of company-wide experience
Experienced clinical pharmacology clearance team
Conducted over a hundred Hepatic protocols
Enrolled over a thousand hepatic impaired subjects
DCR’s active database of hepatic impaired subjects consists of 633 Child Pugh A (Mild), B (Moderate), C (Severe) hepatic impaired volunteers